Confirming the lack of significance of CD8+ T cell enrichment score for survival, we found a lower CD8+ T cell enrichment score in the more favorable IDH mutant when compared with IDH wild-type gliomas (Wilcoxon p-value 2.26E–16, Supplementary Fig. 9b). This evidence concerns the gene CD8A and central nervous system cancer.